Last reviewed · How we verify
Measles, Mumps, and Rubella — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Vaccine Support Cp | Vaccine administration | Women and Infants Hospital of Rhode Island | vaccine | unknown |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Women and Infants Hospital of Rhode Island · 1 drug in Measles, Mumps, and Rubella
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Measles, Mumps, and Rubella:
- Measles, Mumps, and Rubella treatment updates — RSS
- Measles, Mumps, and Rubella treatment updates — Atom
- Measles, Mumps, and Rubella treatment updates — JSON
Cite this brief
Drug Landscape (2026). Measles, Mumps, and Rubella — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/measles-mumps-and-rubella. Accessed 2026-06-11.
Related
- Measles, Mumps, and Rubella full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing